Metabolic HealthResearch PaperPaywall

Brain Immune Cells Sense Succinate to Help Control Whole-Body Energy Balance

In mice, microglia use the succinate receptor SUCNR1 to read metabolic state and tune leptin response and feeding. Deleting it shielded against diet stress but disrupted normal energy balance.

Wednesday, November 18, 2026 0 views
Published in Cell Metab
a researcher pipetting clear fluid into a multi-well plate beside a mouse brain tissue section under a microscope

Summary

Succinate, a Krebs cycle byproduct that rises with overeating and inflammation, may act as a signal to the brain. This study, mainly in mice with supporting human and cell work, found that cerebrospinal fluid succinate is regulated separately from blood succinate yet tracks the body's metabolic status. The brain's resident immune cells, microglia, were the main cells responding to it through the receptor SUCNR1. When researchers deleted this receptor in microglia, mice resisted some effects of a high-fat diet, but their normal energy regulation was impaired, including leptin responsiveness and feeding behavior after fasting. The work points to microglia as a link between metabolic state and hypothalamic control of energy balance. It is a mechanistic finding, not a treatment, and effects on lifespan or human outcomes were not reported in the abstract.

Detailed Summary

Why it matters: Obesity, insulin resistance and metabolic decline are central drivers of age-related disease. The brain, especially the hypothalamus, sets energy balance, but how peripheral metabolic signals reach it is incompletely understood. Succinate, a Krebs cycle metabolite that rises with nutrient excess and inflammation, is a candidate messenger, signaling through the receptor SUCNR1.

What was studied: The authors used an integrated approach combining mouse models, human samples and cellular experiments to ask how the succinate-SUCNR1 axis affects peripheral energy balance under normal and high-fat diet conditions. They measured succinate in cerebrospinal fluid and plasma, ran multi-omic and functional analyses to identify which central nervous system cells respond, and deleted Sucnr1 specifically in microglia.

Key results: Cerebrospinal fluid succinate dynamics were dissociated from plasma levels yet reflected systemic metabolic status, suggesting a distinct central succinate compartment. Microglia emerged as the principal central targets, with high SUCNR1 expression and functional dependence on the pathway. Microglial Sucnr1 deletion altered peripheral energy regulation. It conferred resistance to diet-induced metabolic stress, but also disrupted physiological energy balance, including leptin responsiveness and fasting-refeeding behavior.

Implications: The findings frame microglia as immuno-metabolic sensors linking body-wide metabolic signals to hypothalamic control of energy homeostasis. This is a mechanism: it shows how a pathway works, not that targeting it improves function or lifespan in people. The dual result matters. Genetically deleting the receptor in microglia protected against diet stress but impaired normal regulation, so any therapeutic idea must weigh that trade-off. Pharmacological blockade was not reported in the abstract.

Caveats: This summary rests on the abstract only. Sample sizes, sex distribution, human cohort details and effect sizes are not available. Lifespan was not reported. Two authors (S.F.-V. and J.V.) hold patents related to succinate biology and co-founded SUCCIPRO S.L., a company developing succinate-modulating therapies for inflammatory diseases. They state the article is unrelated to the company's assets.

Key Findings

  • Mechanism: cerebrospinal fluid succinate is regulated separately from plasma succinate yet reflects systemic metabolic status.
  • Mechanism: microglia are the main CNS cells responding to succinate, with high SUCNR1 expression and functional dependence.
  • Function: microglial Sucnr1 deletion conferred resistance to diet-induced metabolic stress in mice.
  • Harm/trade-off: the same deletion disrupted leptin responsiveness and fasting-refeeding behavior, impairing normal energy balance.
  • Lifespan effects and human interventional outcomes were not reported in the abstract.

Methodology

Integrated mouse, human and cellular approaches, including cerebrospinal fluid and plasma succinate measurements, multi-omic and functional analyses, and microglia-specific Sucnr1 deletion under normal and high-fat diets. Sample sizes and human cohort details are not stated in the abstract.

Study Limitations

This summary is based on the abstract only, so design details, sample sizes, sex-specific results and effect sizes could not be assessed. Evidence is primarily from mice, and human data appear limited to supporting measurements. Lifespan was not reported. Two authors hold succinate-related patents and co-founded SUCCIPRO S.L., a succinate-therapy company, though they state the article is unrelated to its assets.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: